Concept Life Sciences Acquires CXR Biosciences To Augment Its Expanding Service Base In Discovery And PreClinical Sciences
PressReleasePing
Concept Life Sciences acquires CXR
Biosciences to augment its expanding service base in Discovery and PreClinical
Sciences
LONDON: Concept Life Sciences, scientific Laboratory and consultancy group has acquired
CXR Biosciences. This marks its fourth acquisition since it was formed in July 2014. Led by
Executive Chairman Michael Fort and Chief Executive Officer Alan Morgan the Concept Life
Sciences Group currently has over 600 staff in 11 core locations, with advanced plans for further expansion into continental Europe.
LONDON, UK, August 19, 2015 /PressReleasePing/ - Concept Life Sciences, scientific
Laboratory and consultancy group has acquired CXR Biosciences. This marks its fourth acquisition since it was formed in July 2014. Led by Executive Chairman Michael Fort and
Chief Executive Officer Alan Morgan tnhe Concept Life Sciences Group currently has over
600 staff in 11 core locations, with advanced plans for further expansion into continental
Europe.
CXR Biosciences is a leading investigative toxicology business. Its in-house expertise assists international life sciences companies to resolve issues relating to the safety of compounds and with the selection of drug and chemical candidates. The company was eyed as an acquisition target as it complements Concept Life Sciences’ existing platform of problem solving chemical synthesis and biological services. The acquisition of CXR Biosciences further strengthens Concept Life Sciences’ portfolio offering and enhances its ability to support its customer’s complex discovery projects.
The CXR Biosciences team comprises staff from both industrial and academic backgrounds; over 50 per cent of whom have PhDs bringing Concept’s total number of PhDs to over 120.
CXR Biosciences will retain its name and operate under the Concept Life Sciences Group umbrella. All staff including the management team will be joining the Concept Life Sciences’
Group. CXR Biosciences CEO, Paul Smith will continue to head up the
Concept Life Sciences acquires CXR
Biosciences to augment its expanding service base in Discovery and PreClinical
Sciences
LONDON: Concept Life Sciences, scientific Laboratory and consultancy group has acquired
CXR Biosciences. This marks its fourth acquisition since it was formed in July 2014. Led by
Executive Chairman Michael Fort and Chief Executive Officer Alan Morgan the Concept Life
Sciences Group currently has over 600 staff in 11 core locations, with advanced plans for further expansion into continental Europe.
LONDON, UK, August 19, 2015 /PressReleasePing/ - Concept Life Sciences, scientific
Laboratory and consultancy group has acquired CXR Biosciences. This marks its fourth acquisition since it was formed in July 2014. Led by Executive Chairman Michael Fort and
Chief Executive Officer Alan Morgan tnhe Concept Life Sciences Group currently has over
600 staff in 11 core locations, with advanced plans for further expansion into continental
Europe.
CXR Biosciences is a leading investigative toxicology business. Its in-house expertise assists international life sciences companies to resolve issues relating to the safety of compounds and with the selection of drug and chemical candidates. The company was eyed as an acquisition target as it complements Concept Life Sciences’ existing platform of problem solving chemical synthesis and biological services. The acquisition of CXR Biosciences further strengthens Concept Life Sciences’ portfolio offering and enhances its ability to support its customer’s complex discovery projects.
The CXR Biosciences team comprises staff from both industrial and academic backgrounds; over 50 per cent of whom have PhDs bringing Concept’s total number of PhDs to over 120.
CXR Biosciences will retain its name and operate under the Concept Life Sciences Group umbrella. All staff including the management team will be joining the Concept Life Sciences’
Group. CXR Biosciences CEO, Paul Smith will continue to head up the